Cargando…

Influence of Paclitaxel and Heparin on Vitality, Proliferation and Cytokine Production of Endometrial Cancer Cells

BACKGROUND: Cancer patients have a higher risk for thromboembolic events compared to healthy individuals and are often treated with heparins. A beneficial effect of heparins on tumor patients above and beyond the classic anticoagulation effect has been reported, leading to an increased focus on the...

Descripción completa

Detalles Bibliográficos
Autores principales: Dinkic, Christine, Kruse, Anja, Zygmunt, Marek, Schuetz, Florian, Brucker, Janina, Rom, Joachim, Sohn, Christof, Fluhr, Herbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2017
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658230/
https://www.ncbi.nlm.nih.gov/pubmed/29093604
http://dx.doi.org/10.1055/s-0043-119289
_version_ 1783273956344594432
author Dinkic, Christine
Kruse, Anja
Zygmunt, Marek
Schuetz, Florian
Brucker, Janina
Rom, Joachim
Sohn, Christof
Fluhr, Herbert
author_facet Dinkic, Christine
Kruse, Anja
Zygmunt, Marek
Schuetz, Florian
Brucker, Janina
Rom, Joachim
Sohn, Christof
Fluhr, Herbert
author_sort Dinkic, Christine
collection PubMed
description BACKGROUND: Cancer patients have a higher risk for thromboembolic events compared to healthy individuals and are often treated with heparins. A beneficial effect of heparins on tumor patients above and beyond the classic anticoagulation effect has been reported, leading to an increased focus on the use of heparins in anticancer treatment. In recent years, it has become apparent that microenvironments greatly affect tumor development and can be a major source of tumor-promoting factors. Cytokines play an important role in tumor microenvironments, inducing carcinogenesis and influencing tumor progression by promoting angiogenesis, metastatic potential and immunosuppression. The possible interaction of heparins and cytokines could also have an effect on cancer cells. METHODS: This study investigated the effect of paclitaxel (PTX) combined with heparins on the vitality of endometrial cancer cells using viability and cytotoxicity assays. The study also examined whether treatment with paclitaxel and heparin influences cytokine secretion or expression. RESULTS: Heparin treatment did not influence cell viability, and no influence of heparins in combination with paclitaxel was seen for the evaluated cancer cell lines HEC-1-A, KLE, RL 95-2 and AN3-CA compared to untreated cells. Secretion of the cytokines CCL5, CCL2 and IL-6 increased after paclitaxel treatment in several endometrial cancer cell lines, but no general effect on cytokine secretion was detected after heparin treatment. A significant decrease in CCL5 expression was only detected in KLE cells following treatment with heparin and paclitaxel, and an increase in the expression of CCL5 in RL 95-2 cells. CONCLUSION: Further in-depth studies are needed to investigate the functions of cytokines CCL2, CCL5 and IL-6 in endometrial cancer cells treated with paclitaxel. Although no general effect on cytokine secretion was detected following heparin treatment, a selective modulatory impact could exist.
format Online
Article
Text
id pubmed-5658230
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Georg Thieme Verlag KG
record_format MEDLINE/PubMed
spelling pubmed-56582302017-10-30 Influence of Paclitaxel and Heparin on Vitality, Proliferation and Cytokine Production of Endometrial Cancer Cells Dinkic, Christine Kruse, Anja Zygmunt, Marek Schuetz, Florian Brucker, Janina Rom, Joachim Sohn, Christof Fluhr, Herbert Geburtshilfe Frauenheilkd BACKGROUND: Cancer patients have a higher risk for thromboembolic events compared to healthy individuals and are often treated with heparins. A beneficial effect of heparins on tumor patients above and beyond the classic anticoagulation effect has been reported, leading to an increased focus on the use of heparins in anticancer treatment. In recent years, it has become apparent that microenvironments greatly affect tumor development and can be a major source of tumor-promoting factors. Cytokines play an important role in tumor microenvironments, inducing carcinogenesis and influencing tumor progression by promoting angiogenesis, metastatic potential and immunosuppression. The possible interaction of heparins and cytokines could also have an effect on cancer cells. METHODS: This study investigated the effect of paclitaxel (PTX) combined with heparins on the vitality of endometrial cancer cells using viability and cytotoxicity assays. The study also examined whether treatment with paclitaxel and heparin influences cytokine secretion or expression. RESULTS: Heparin treatment did not influence cell viability, and no influence of heparins in combination with paclitaxel was seen for the evaluated cancer cell lines HEC-1-A, KLE, RL 95-2 and AN3-CA compared to untreated cells. Secretion of the cytokines CCL5, CCL2 and IL-6 increased after paclitaxel treatment in several endometrial cancer cell lines, but no general effect on cytokine secretion was detected after heparin treatment. A significant decrease in CCL5 expression was only detected in KLE cells following treatment with heparin and paclitaxel, and an increase in the expression of CCL5 in RL 95-2 cells. CONCLUSION: Further in-depth studies are needed to investigate the functions of cytokines CCL2, CCL5 and IL-6 in endometrial cancer cells treated with paclitaxel. Although no general effect on cytokine secretion was detected following heparin treatment, a selective modulatory impact could exist. Georg Thieme Verlag KG 2017-10 2017-10-26 /pmc/articles/PMC5658230/ /pubmed/29093604 http://dx.doi.org/10.1055/s-0043-119289 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle Dinkic, Christine
Kruse, Anja
Zygmunt, Marek
Schuetz, Florian
Brucker, Janina
Rom, Joachim
Sohn, Christof
Fluhr, Herbert
Influence of Paclitaxel and Heparin on Vitality, Proliferation and Cytokine Production of Endometrial Cancer Cells
title Influence of Paclitaxel and Heparin on Vitality, Proliferation and Cytokine Production of Endometrial Cancer Cells
title_full Influence of Paclitaxel and Heparin on Vitality, Proliferation and Cytokine Production of Endometrial Cancer Cells
title_fullStr Influence of Paclitaxel and Heparin on Vitality, Proliferation and Cytokine Production of Endometrial Cancer Cells
title_full_unstemmed Influence of Paclitaxel and Heparin on Vitality, Proliferation and Cytokine Production of Endometrial Cancer Cells
title_short Influence of Paclitaxel and Heparin on Vitality, Proliferation and Cytokine Production of Endometrial Cancer Cells
title_sort influence of paclitaxel and heparin on vitality, proliferation and cytokine production of endometrial cancer cells
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658230/
https://www.ncbi.nlm.nih.gov/pubmed/29093604
http://dx.doi.org/10.1055/s-0043-119289
work_keys_str_mv AT dinkicchristine influenceofpaclitaxelandheparinonvitalityproliferationandcytokineproductionofendometrialcancercells
AT kruseanja influenceofpaclitaxelandheparinonvitalityproliferationandcytokineproductionofendometrialcancercells
AT zygmuntmarek influenceofpaclitaxelandheparinonvitalityproliferationandcytokineproductionofendometrialcancercells
AT schuetzflorian influenceofpaclitaxelandheparinonvitalityproliferationandcytokineproductionofendometrialcancercells
AT bruckerjanina influenceofpaclitaxelandheparinonvitalityproliferationandcytokineproductionofendometrialcancercells
AT romjoachim influenceofpaclitaxelandheparinonvitalityproliferationandcytokineproductionofendometrialcancercells
AT sohnchristof influenceofpaclitaxelandheparinonvitalityproliferationandcytokineproductionofendometrialcancercells
AT fluhrherbert influenceofpaclitaxelandheparinonvitalityproliferationandcytokineproductionofendometrialcancercells